(Q40343915)

English

Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma: results from a phase II feasibility study.

scientific article published on 10 November 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063792%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma: results from a phase II feasibility study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063792%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

gastroesophageal junction adenocarcinoma

0 references

chemoradiotherapy

0 references

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063792%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

G Spizzo

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063792%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

D Öfner

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063792%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

A de Vries

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063792%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

P Lukas

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063792%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

G Steger

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063792%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

U Pluschnig

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063792%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

J Zacherl

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063792%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

A Zabernigg

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063792%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

G Gastl

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063792%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

G Mühlmann

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063792%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

10 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063792%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Annals of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063792%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063792%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063792%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

677-683

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21063792%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1388-2

21 January 2018

Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO).

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1388-2

21 January 2018

Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1388-2

21 January 2018

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1388-2

21 January 2018

Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1388-2

21 January 2018

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1388-2

21 January 2018

Japanese Classification of Gastric Carcinoma - 2nd English Edition -

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1388-2

21 January 2018

Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1388-2

21 January 2018

Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1388-2

21 January 2018

Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1388-2

21 January 2018

Phase II study of bi-weekly administration of paclitaxel and cisplatin in patients with advanced oesophageal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1388-2

21 January 2018

A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1388-2

21 January 2018

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

1 reference

https://api.crossref.org/works/10.1245%2FS10434-010-1388-2

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40343915&oldid=2203617687"